Bispecific HIV-1 neutralizing antibodies
US9587012B2 · kind B2 · utility
1Cited by
3References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 2, 2014 |
| Grant date | Mar 7, 2017 |
| Priority date | — |
| Expiry date | Dec 2, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/94
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
In various embodiments, the present invention relates generally to using bispecific antibodies in the prevention and treatment of HIV.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.